Charles N. York Ii.
Chief Financial Officer, Aeglea BioTherapeutics.
Companies
- Day One Biopharmaceuticals, Inc.Chief financial officer May 26, 2021 to now1
- Day One Biopharmaceuticals, Inc.Chief operating officer May 26, 2021 to now1
- Aeglea BioTherapeuticsChief financial officer Apr 6, 2016 to Feb 19, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Day One Biopharmaceuticals, Inc.0 shares3Apr 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 23, 2026Returned to company 312,025 shares of Day One Biopharmaceuticals, Inc.3
- Feb 17, 2026Sold 6,065 shares at $11.60 of Day One Biopharmaceuticals, Inc.4
- Feb 15, 2026Exercised options 7,875 shares of Day One Biopharmaceuticals, Inc.4
- Feb 15, 2026Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.4
- Feb 15, 2026Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.4
- Feb 15, 2026Exercised options 2,250 shares of Day One Biopharmaceuticals, Inc.4
- Nov 17, 2025Sold 4,062 shares at $8.91 of Day One Biopharmaceuticals, Inc.5
- Nov 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.5
- Nov 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.5
- Nov 15, 2025Exercised options 2,250 shares of Day One Biopharmaceuticals, Inc.5
- Nov 15, 2025Exercised options 1,375 shares of Day One Biopharmaceuticals, Inc.5
- Aug 18, 2025Sold 4,106 shares at $6.77 of Day One Biopharmaceuticals, Inc.6
- Aug 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.6
- Aug 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.6
- Aug 15, 2025Exercised options 2,250 shares of Day One Biopharmaceuticals, Inc.6
- Aug 15, 2025Exercised options 1,375 shares of Day One Biopharmaceuticals, Inc.6
- May 16, 2025Sold 4,282 shares at $6.26 of Day One Biopharmaceuticals, Inc.7
- May 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.7
- May 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.7
- May 15, 2025Exercised options 2,250 shares of Day One Biopharmaceuticals, Inc.7
- May 15, 2025Exercised options 1,375 shares of Day One Biopharmaceuticals, Inc.7
- Feb 18, 2025Sold 4,370 shares at $11.96 of Day One Biopharmaceuticals, Inc.8
- Feb 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.8
- Feb 15, 2025Exercised options 6,625 shares of Day One Biopharmaceuticals, Inc.8
- Feb 15, 2025Exercised options 2,250 shares of Day One Biopharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 18, 2026
- 5SEC EDGARForm 4 filed Nov 18, 2025
- 6SEC EDGARForm 4 filed Aug 19, 2025
- 7SEC EDGARForm 4 filed May 19, 2025
- 8SEC EDGARForm 4 filed Feb 21, 2025